iSTAR Medical
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
iSTAR Medical - overview
Established
2010
Location
Wavre, -, Belgium
Primary Industry
Medical Devices & Equipment
About
Based in Belgium, and founded in 2010, iSTAR Medical, operates as a developer of medical devices used for providing various eye care solutions to patients. In September 2019, iSTAR Medical SA raised EUR 40. 1 million in series C funding co-led by Gimv and EQT Life Sciences, with participation from BNP Paribas Fortis Private Equity and Earlybird Venture Capital. In July 2022, Abbvie agreed to acquire iSTAR Medical SA for USD 60 million.
As of 2024, the company is led by Chief Executive Officer (CEO), Michel Vanbrabant. iSTAR Medical offers various healthcare solutions that include devices like the minimally invasive glaucoma surgery (MIGS) device used for the treatment of eyes with open-angle glaucoma and helping in the reduction of intraocular pressure (IOP). The company’s product portfolio includes STARflo, a micro-porous drainage system that increases the eye's natural uveoscleral outflow, and MINIject, an ab interno MIGS device that enhances the eye's aqueous humour outflow.
Current Investors
Capricorn Partners, Demea Invest, Société Régionale d'Investissement de Wallonie
Primary Industry
Medical Devices & Equipment
Sub Industries
Optometrists & Opticians Products and Services, Therapeutic Devices, Surgical Devices
Website
www.istar-medical.com
Verticals
HealthTech, Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.